Davide Recchia

Rex Medical (United States)

Papers

1

Total Citations

2

H-Index

1

About

Davide Recchia is pioneering the frontier of autonomous robotic systems for minimally invasive cardiac surgery, with a primary focus on transcatheter aortic valve implantation (TAVI). His research integrates artificial intelligence, robotic teleoperation, and intraoperative imaging to enhance the precision and safety of heart valve positioning. In his landmark 2025 study, Recchia demonstrated the first in vivo teleoperation and AI-guided phantom validation of autonomous TAVI, achieving submillimeter accuracy in valve deployment—a critical step toward reducing complications like paravalvular leakage and conduction disturbances. This work, already garnering early citations, positions him at the vanguard of surgical robotics. Recchia’s contributions extend beyond technical innovation; he bridges the gap between clinical need and engineering feasibility, addressing the growing demand for TAVI in younger, intermediate-risk patients. By developing algorithms that adapt to real-time anatomical changes, his research promises to transform complex catheter-based interventions into safer, more reproducible procedures. As the field moves toward full autonomy, Recchia’s foundational studies are shaping the next generation of smart surgical tools, earning him recognition as a rising leader in AI-driven cardiovascular medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Towards autonomous robot-assisted transcatheter heart valve implantation: in vivo teleoperation and phantom validation of AI-guided positioning
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Rex Medical (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago